In-Vitro Diagnostic (IVD) MarketMarket Reports 

Precise Growth of US IVD Market Impact of Existing and Emerging Flexible Trends and International Top Key Players (Thermo Fisher, Roche, Abbott, Danaher, Bio-Rad Lab) | Future Outlook 2020-2025

Press Release

This report provides in-depth study on the current state of the United States IVD Market 2020-2025. Key players in the United States IVD Market have been identified through the secondary research and their market share has been determined through primary and secondary research. These include a study of annual and financial reports of top players and extensive interviews of leaders including CEOs, directors, and marketing executives.

Overview of United States IVD Market:

United States In Vitro Diagnostics (IVD) Market is expected to reach US$ 33.7 Billion by 2025. United States represents the largest IVD market across the world. With an aging population, technological advances and advent of point of care diagnostics, United States IVD market is slated to show substantial growth in the future.

The increase in the US in vitro diagnostics market is majorly driven by high prevalence of chronic diseases, such as heart diseases, cancer, asthma, and diabetes. It is estimated that these diseases are responsible for the majority of deaths in the United States, killing more than 1.7 million US citizens annually. All of these conditions can be diagnosed and monitored using IVD products. Thus, IVDs have proved to be beneficial in managing these chronic conditions. However, some of the factors limiting the growth of the market are a lack of proper reimbursement policies and lack of skilled lab technicians.

Available Exclusive Sample Copy of this Report @ .

United States In-Vitro Diagnostics Market: Segmentation –

Application Segments Analysis –

1 On the basis of segment, the POC-OTC diabetes diagnostics segment accounted for highest share of the United States in-vitro diagnostics market, followed by the POC – Professional segment.

2 Immunoassays have become one of the primary and indispensable tools in the diagnosis and monitoring of all diseases and medical conditions.

3 The non-infectious immunoassays contribute significantly to the United States IVD market.

4 It is anticipated that the molecular microbiology segment will account for nearly 10% share of the United States IVD market by 2025.

5 The Clinical chemistry segment contributed around 8% to the United States IVD market in 2018.

6 Histology and Hematology segments are competing closely with each other to grab maximum share of the pie.

7 Urinalysis captures least share of the United States in vitro diagnostics market.

Products Analysis –

1 Instruments is the leading product segment of the United States In-Vitro Diagnostics (IVD) market, followed by the reagents segment.

2 The software segment holds close to 15% share of the United States IVD market in 2018, due to growing preference for reliable and efficient diagnostic software.

3 Services segment captured least share of the United States in vitro diagnostics market, but it is likely to show impressive growth throughout the forecast period.

Regional Analysis –

1 The largest share of the US in vitro diagnostics market is currently in the South of the country with the West being second.

2 Midwest region accounts for nearly 22% share of the total US IVD market in 2018, as an increasing number of accredited laboratories opening in that area.

3 The North East region accounted for least share of the total US IVD market.

Top Leading Key Manufacturers in United States IVD Market: Roche Diagnostic, Abbott Laboratories, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Sysmex Corporation, Biomerieux, Bio-Rad Laboratories, Becton Dickinson and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Latest Industry News:

Thermo Fisher Scientific (September 09, 2019) – Thermo Fisher Scientific Signs Agreement with Lilly Oncology for Companion Diagnostic to be Used with RET Inhibitor – Thermo Fisher Scientific today announced an agreement with Eli Lilly and Company for development of a companion diagnostic that will use the U.S Food and Drug Administration-approved, next-generation sequencing-based Oncomine Dx Target Test to identify certain non-small cell lung cancer (NSCLC) and thyroid cancer patients who may be treated with Lilly’s investigational therapy, LOXO-292. Specifically, the test would be used with patients whose tumors harbor a rearranged during transfection (RET) alteration. RET variants are found in about two percent of NSCLC, about 60 percent of medullary thyroid cancer (MTC) and up to approximately 20 percent of other thyroid cancers.

LOXO-292 is a highly selective and potent oral RET inhibitor being studied by Lilly in a Phase 1/2 clinical trial for the treatment of advanced cancers that harbor activating alterations of the RET kinase. Changes in the RET kinase, including fusions and mutations, can cause uncontrolled cell growth leading to tumor development. Cancers driven by such alterations are mostly dependent on this singularly activated pathway, making them highly susceptible to small molecule inhibitors.

Purchase this report online with 201 Pages, List of Tables & Figures and in-depth Table of Contents on “United States IVD Market Report 2020” @ .

Major Points in Table of Contents:

United States IVD Market Report 2020

1 Executive Summary

2 United States – In-Vitro Diagnostics Market and Forecast (2013 – 2025)

3 United States – In-Vitro Diagnostics Market Share and Forecast (2013 – 2025)

3.1 By Application Segments – United States In-Vitro Diagnostics Market Share and Forecast

3.2 By Products – United States In-Vitro Diagnostics Market Share and Forecast

3.3 By Region – United States In-Vitro Diagnostics Market Share and Forecast

3.4 By End Users – United States In-Vitro Diagnostics Market Share and Forecast


8 United States In-Vitro Diagnostics Market – Company Profiles

9 United States IVD Market – Major Deals

10 United States In-Vitro Diagnostics Market – Growth Drivers

11 United States In-Vitro Diagnostics Market – Challenges

………………. Request free sample to get a complete Table of Content

About us is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

[email protected]


Business Industry Reports

Related posts